ArticlePloS one2017

Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.

Diana Klose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.